dapsone

Generic: dapsone

Labeler: seton pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name dapsone
Generic Name dapsone
Labeler seton pharmaceuticals
Dosage Form TABLET
Routes
ORAL
Active Ingredients

dapsone 25 mg/1

Manufacturer
Seton Pharmaceuticals

Identifiers & Regulatory

Product NDC 13925-504
Product ID 13925-504_ec807b3c-14d5-47f0-a239-bff0363ec49b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA086841
Marketing Start 2016-03-04
Marketing End 2026-07-31

Pharmacologic Class

Established (EPC)
sulfone [epc]
Chemical Structure
sulfones [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 13925504
Hyphenated Format 13925-504

Supplemental Identifiers

RxCUI
197557 197558
UPC
0313925504011
UNII
8W5C518302
NUI
N0000175881 M0020791

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name dapsone (source: ndc)
Generic Name dapsone (source: ndc)
Application Number ANDA086841 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (13925-504-01)
source: ndc

Packages (1)

Ingredients (1)

dapsone (25 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ec807b3c-14d5-47f0-a239-bff0363ec49b", "openfda": {"nui": ["N0000175881", "M0020791"], "upc": ["0313925504011"], "unii": ["8W5C518302"], "rxcui": ["197557", "197558"], "spl_set_id": ["229af266-d901-43e2-828a-4931d1124ea3"], "pharm_class_cs": ["Sulfones [CS]"], "pharm_class_epc": ["Sulfone [EPC]"], "manufacturer_name": ["Seton Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (13925-504-01)", "package_ndc": "13925-504-01", "marketing_end_date": "20260731", "marketing_start_date": "20160310"}], "brand_name": "Dapsone", "product_id": "13925-504_ec807b3c-14d5-47f0-a239-bff0363ec49b", "dosage_form": "TABLET", "pharm_class": ["Sulfone [EPC]", "Sulfones [CS]"], "product_ndc": "13925-504", "generic_name": "Dapsone", "labeler_name": "Seton Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dapsone", "active_ingredients": [{"name": "DAPSONE", "strength": "25 mg/1"}], "application_number": "ANDA086841", "marketing_category": "ANDA", "marketing_end_date": "20260731", "marketing_start_date": "20160304"}